ARTV · Company research
Artiva Biotherapeutics, Inc. Common Stock (ARTV): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ARTV Oct 2026 15.000 call (ARTV261016C00015000) Stock Price, News, Quote & History - Yahoo! Finance Canada | ARTV Oct 2026 15.000 call (ARTV261016C00015000) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 15, 2026 | neutral | 0 | 0.6 |
| Artiva Biotherapeutics (ARTV) Short Interest & Short Float | Updated Oct 2026 $ARTV - MarketBeat | Artiva Biotherapeutics (ARTV) Short Interest & Short Float | Updated Oct 2026 $ARTV MarketBeat | View source ↗ | MarketBeat | Oct 9, 2026 | neutral | 0 | 0.6 |
| (ARTV) Volatility Zones as Tactical Triggers - Stock Traders Daily | (ARTV) Volatility Zones as Tactical Triggers Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 7, 2026 | neutral | 0 | 0.6 |
| Artiva Biotherapeutics, Inc. (ARTV) stock price, news, quote and history - Yahoo Finance UK | Artiva Biotherapeutics, Inc. (ARTV) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Oct 3, 2026 | neutral | 0 | 0.6 |
| A cell treatment and a drug depleted antibody-making immune cells in 60 people with rheumatic diseases - Stock Titan | A cell treatment and a drug depleted antibody-making immune cells in 60 people with rheumatic diseases Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Trial data show symptom and saliva-flow improvements after six months in 11 people with Sjögren disease - Stock Titan | Trial data show symptom and saliva-flow improvements after six months in 11 people with Sjögren disease Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Artiva Biotherapeutics (NasdaqGM:ARTV) Stock Forecast & Analyst Predictions - Simply Wall Street | Artiva Biotherapeutics (NasdaqGM:ARTV) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 1, 2026 | neutral | 0 | 0.6 |
| The Technical Signals Behind (ARTV) That Institutions Follow - Stock Traders Daily | The Technical Signals Behind (ARTV) That Institutions Follow Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 27, 2026 | neutral | 0 | 0.6 |
| Artiva's online investor talk will stay available for 90 days - Stock Titan | Artiva's online investor talk will stay available for 90 days Stock Titan | View source ↗ | Stock Titan | Sep 17, 2026 | neutral | 0 | 0.6 |
| $ARTV stock is down 12% today. Here's what we see in our data. - Quiver Quantitative | $ARTV stock is down 12% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Sep 15, 2026 | neutral | 0 | 0.6 |
| Artiva Biotherapeutics: Targeting A Potentially Lucrative Niche (NASDAQ:ARTV) - Seeking Alpha | Artiva Biotherapeutics: Targeting A Potentially Lucrative Niche (NASDAQ:ARTV) Seeking Alpha | View source ↗ | Seeking Alpha | Aug 18, 2026 | neutral | 0 | 0.6 |
| $ARTV stock is up 9% today. Here's what we see in our data. - Quiver Quantitative | $ARTV stock is up 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 17, 2026 | neutral | 0 | 0.6 |
| Should I buy Artiva Biotherapeutics, Inc. (ARTV) - Zacks Investment Research | Should I buy Artiva Biotherapeutics, Inc. (ARTV) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jul 8, 2026 | neutral | 0 | 0.6 |
| ARTV Forecast — Price Target — Prediction for 2027 - TradingView | ARTV Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: 10% owner at $ARTV Buys 347,222 Shares | ARTV Stock News - Quiver Quantitative | Insider Purchase: 10% owner at $ARTV Buys 347,222 Shares | ARTV Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | May 28, 2026 | neutral | 0 | 0.6 |
| ARTV Stock Pares Majority Of Pre-Market Gains – $300M Offering Overshadows Strong Data For Rheumatoid Arthritis Therapy - Stocktwits | ARTV Stock Pares Majority Of Pre-Market Gains – $300M Offering Overshadows Strong Data For Rheumatoid Arthritis Therapy Stocktwits | View source ↗ | Stocktwits | May 8, 2026 | neutral | 0 | 0.6 |
| ARTV Stock Price and Chart — NASDAQ:ARTV - TradingView | ARTV Stock Price and Chart — NASDAQ:ARTV TradingView | View source ↗ | TradingView | Feb 6, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.